Latest Insider Transactions at Acurx Pharmaceuticals, Inc. (ACXP)
This section provides a real-time view of insider transactions for Acurx Pharmaceuticals, Inc. (ACXP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Acurx Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Acurx Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2024
|
Carl Sailer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,737
+14.92%
|
$59,211
$3.55 P/Share
|
|
Jan 03
2024
|
David P Luci President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,737
+1.85%
|
$59,211
$3.55 P/Share
|
|
Jan 03
2024
|
Robert J Deluccia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,737
+2.01%
|
$59,211
$3.55 P/Share
|
|
Dec 22
2023
|
Robert J Deluccia Director |
SELL
Bona fide gift
|
Direct |
30,000
-3.09%
|
-
|
|
Dec 12
2023
|
Robert J Deluccia Director |
SELL
Bona fide gift
|
Direct |
40,000
-3.96%
|
-
|
|
Jul 27
2022
|
David P Luci President and CEO |
BUY
Open market or private purchase
|
Direct |
19,737
+1.88%
|
$59,211
$3.8 P/Share
|
|
Jul 27
2022
|
Robert J Deluccia Director |
BUY
Open market or private purchase
|
Direct |
19,737
+1.84%
|
$59,211
$3.8 P/Share
|
|
Jul 27
2022
|
Carl Sailer Director |
BUY
Open market or private purchase
|
Direct |
19,737
+17.54%
|
$59,211
$3.8 P/Share
|
|
Dec 02
2021
|
Robert J Deluccia Director |
SELL
Bona fide gift
|
Direct |
40,000
-3.81%
|
-
|
|
Nov 23
2021
|
Carl Sailer Director |
BUY
Open market or private purchase
|
Direct |
5,161
+6.6%
|
$20,644
$4.84 P/Share
|
|
Nov 19
2021
|
David P Luci President and CEO |
BUY
Open market or private purchase
|
Direct |
5,200
+0.51%
|
$20,800
$4.8 P/Share
|
|
Nov 19
2021
|
Robert J Deluccia Director |
BUY
Open market or private purchase
|
Direct |
5,034
+0.49%
|
$20,136
$4.9 P/Share
|
|
Jun 29
2021
|
Carl Sailer Director |
BUY
Open market or private purchase
|
Direct |
12,500
+15.54%
|
$75,000
$6.0 P/Share
|